Literature DB >> 27778206

A prospective study of peripheral blood DNA methylation at RPTOR, MGRN1 and RAPSN and risk of breast cancer.

Pierre-Antoine Dugué1,2, Roger L Milne1,2, Melissa C Southey3,4.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27778206     DOI： 10.1007/s10549-016-4032-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  5 in total

1.  Pyrroline-5-carboxylate reductase 1 promotes cell proliferation via inhibiting apoptosis in human malignant melanoma.

Authors:  Yingyi Ye; Yingying Wu; Jinyan Wang
Journal:  Cancer Manag Res       Date:  2018-11-27       Impact factor: 3.989

2.  Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies.

Authors:  Clara Bodelon; Srikant Ambatipudi; Pierre-Antoine Dugué; Annelie Johansson; Joshua N Sampson; Belynda Hicks; Eric Karlins; Amy Hutchinson; Cyrille Cuenin; Veronique Chajès; Melissa C Southey; Isabelle Romieu; Graham G Giles; Dallas English; Silvia Polidoro; Manuela Assumma; Laura Baglietto; Paolo Vineis; Gianluca Severi; Zdenko Herceg; James M Flanagan; Roger L Milne; Montserrat Garcia-Closas
Journal:  Breast Cancer Res       Date:  2019-05-17       Impact factor: 6.466

3.  Longitudinal study of leukocyte DNA methylation and biomarkers for cancer risk in older adults.

Authors:  Alexandra H Bartlett; Jane W Liang; Jose Vladimir Sandoval-Sierra; Jay H Fowke; Eleanor M Simonsick; Karen C Johnson; Khyobeni Mozhui
Journal:  Biomark Res       Date:  2019-05-28

4.  Promoter Methylation of the MGRN1 Gene Predicts Prognosis and Response to Chemotherapy of High-Grade Serous Ovarian Cancer Patients.

Authors:  Xiao-Fei Li; Hai-Yan Sun; Tian Hua; Hai-Bo Zhang; Yun-Jie Tian; Yan Li; Shan Kang
Journal:  Front Oncol       Date:  2021-06-29       Impact factor: 6.244

5.  Epigenome-wide DNA methylation and risk of breast cancer: a systematic review.

Authors:  Kaoutar Ennour-Idrissi; Dzevka Dragic; Francine Durocher; Caroline Diorio
Journal:  BMC Cancer       Date:  2020-10-31       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.